---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-049426"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2026-07-23T20:51:27+00:00"
generated_at: "2026-07-23T20:52:23.440312+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics amends CEO Steve Ledger's employment agreement with enhanced severance and equity acceleration

## Summary
- Base salary of $500,000 unchanged; target annual bonus set at 50% of base salary.
- Non-CIC termination severance: 12 months base salary plus pro-rated target bonus, 12 months COBRA.
- CIC termination severance: 1.5x base salary plus 1.5x target bonus plus pro-rated bonus, 18 months COBRA.
- Full acceleration of unvested time-based equity awards upon a Qualifying CIC Termination.
- Non-compete covenant for 2 years; non-solicit and no-hire for 18 months post-termination.

## SEC filing metadata
- accession: 0001628280-26-049426
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2026-07-23T20:51:27+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000162828026049426/0001628280-26-049426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000162828026049426/ser-20260719.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-049426
- JSON: https://secwatch.observer/filing/0001628280-26-049426.json
- Plain text: https://secwatch.observer/filing/0001628280-26-049426.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.